KR100603814B1 - 나노리포좀 조성물 - Google Patents
나노리포좀 조성물 Download PDFInfo
- Publication number
- KR100603814B1 KR100603814B1 KR1020040016334A KR20040016334A KR100603814B1 KR 100603814 B1 KR100603814 B1 KR 100603814B1 KR 1020040016334 A KR1020040016334 A KR 1020040016334A KR 20040016334 A KR20040016334 A KR 20040016334A KR 100603814 B1 KR100603814 B1 KR 100603814B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- composition
- delete
- group
- nanoliposome
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 64
- 239000002502 liposome Substances 0.000 title abstract description 64
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 45
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 29
- 239000000284 extract Substances 0.000 claims description 25
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 18
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 18
- 229940106189 ceramide Drugs 0.000 claims description 18
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 18
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 18
- 239000002253 acid Substances 0.000 claims description 16
- 235000012000 cholesterol Nutrition 0.000 claims description 14
- 229940109529 pomegranate extract Drugs 0.000 claims description 11
- 229940069445 licorice extract Drugs 0.000 claims description 9
- 244000146462 Centella asiatica Species 0.000 claims description 8
- 235000004032 Centella asiatica Nutrition 0.000 claims description 8
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims description 8
- 235000008696 isoflavones Nutrition 0.000 claims description 8
- 229930182558 Sterol Natural products 0.000 claims description 7
- 150000003432 sterols Chemical class 0.000 claims description 7
- 235000003702 sterols Nutrition 0.000 claims description 7
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims description 6
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims description 6
- 235000021283 resveratrol Nutrition 0.000 claims description 6
- 229940016667 resveratrol Drugs 0.000 claims description 6
- 235000020748 rosemary extract Nutrition 0.000 claims description 6
- 229940092258 rosemary extract Drugs 0.000 claims description 6
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 claims description 6
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 claims description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 5
- KILNVBDSWZSGLL-KXQOOQHDSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-KXQOOQHDSA-N 0.000 claims description 4
- SNKAWJBJQDLSFF-NVKMUCNASA-N 1,2-dioleoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC SNKAWJBJQDLSFF-NVKMUCNASA-N 0.000 claims description 4
- 102000008186 Collagen Human genes 0.000 claims description 4
- 108010035532 Collagen Proteins 0.000 claims description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 4
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims description 4
- 229920001436 collagen Polymers 0.000 claims description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 claims description 4
- 235000005152 nicotinamide Nutrition 0.000 claims description 4
- 229960003966 nicotinamide Drugs 0.000 claims description 4
- 239000011570 nicotinamide Substances 0.000 claims description 4
- OWVLYQRCCIEOPF-QHTZZOMLSA-L zinc;(2s)-5-oxopyrrolidine-2-carboxylate Chemical compound [Zn+2].[O-]C(=O)[C@@H]1CCC(=O)N1.[O-]C(=O)[C@@H]1CCC(=O)N1 OWVLYQRCCIEOPF-QHTZZOMLSA-L 0.000 claims description 4
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 claims description 3
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 claims description 3
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 claims description 3
- 229940087603 grape seed extract Drugs 0.000 claims description 3
- 235000002532 grape seed extract Nutrition 0.000 claims description 3
- 235000020688 green tea extract Nutrition 0.000 claims description 3
- 229940094952 green tea extract Drugs 0.000 claims description 3
- 229940100243 oleanolic acid Drugs 0.000 claims description 3
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 claims description 3
- 239000001717 vitis vinifera seed extract Substances 0.000 claims description 3
- NRJAVPSFFCBXDT-HUESYALOSA-N 1,2-distearoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC NRJAVPSFFCBXDT-HUESYALOSA-N 0.000 claims description 2
- XUGISPSHIFXEHZ-UHFFFAOYSA-N 3beta-acetoxy-cholest-5-ene Natural products C1C=C2CC(OC(C)=O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 XUGISPSHIFXEHZ-UHFFFAOYSA-N 0.000 claims description 2
- YEYCQJVCAMFWCO-UHFFFAOYSA-N 3beta-cholesteryl formate Natural products C1C=C2CC(OC=O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 YEYCQJVCAMFWCO-UHFFFAOYSA-N 0.000 claims description 2
- 241000906543 Actaea racemosa Species 0.000 claims description 2
- 241001288870 Angelica polymorpha Species 0.000 claims description 2
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 claims description 2
- 235000017647 Brassica oleracea var italica Nutrition 0.000 claims description 2
- 239000002126 C01EB10 - Adenosine Substances 0.000 claims description 2
- 239000006000 Garlic extract Substances 0.000 claims description 2
- 239000009429 Ginkgo biloba extract Substances 0.000 claims description 2
- 241000219780 Pueraria Species 0.000 claims description 2
- 241000218206 Ranunculus Species 0.000 claims description 2
- 241000519989 Scutellaria galericulata Species 0.000 claims description 2
- 241000219793 Trifolium Species 0.000 claims description 2
- JBBRZDLNVILTDL-XNTGVSEISA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 16-methylheptadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCC(C)C)C1 JBBRZDLNVILTDL-XNTGVSEISA-N 0.000 claims description 2
- 229960005305 adenosine Drugs 0.000 claims description 2
- 229940069521 aloe extract Drugs 0.000 claims description 2
- 229960000271 arbutin Drugs 0.000 claims description 2
- 229940082487 camellia oleifera seed extract Drugs 0.000 claims description 2
- XUGISPSHIFXEHZ-VEVYEIKRSA-N cholesteryl acetate Chemical compound C1C=C2C[C@@H](OC(C)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 XUGISPSHIFXEHZ-VEVYEIKRSA-N 0.000 claims description 2
- 229940073724 cholesteryl isostearate Drugs 0.000 claims description 2
- 235000005301 cimicifuga racemosa Nutrition 0.000 claims description 2
- 235000020706 garlic extract Nutrition 0.000 claims description 2
- LBQIJVLKGVZRIW-UHFFFAOYSA-N glabridine Natural products C1OC2=C3C=CC(C)(C)OC3=CC=C2CC1C1=CC=C(O)C=C1O LBQIJVLKGVZRIW-UHFFFAOYSA-N 0.000 claims description 2
- 229940065115 grapefruit extract Drugs 0.000 claims description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 claims description 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims description 2
- 229940087126 wild yam extract Drugs 0.000 claims description 2
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 claims 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims 2
- 229930003268 Vitamin C Natural products 0.000 claims 2
- 229920006395 saturated elastomer Polymers 0.000 claims 2
- 235000019154 vitamin C Nutrition 0.000 claims 2
- 239000011718 vitamin C Substances 0.000 claims 2
- 240000003259 Brassica oleracea var. botrytis Species 0.000 claims 1
- 229930193140 Neomycin Natural products 0.000 claims 1
- 229960005188 collagen Drugs 0.000 claims 1
- 229940068052 ginkgo biloba extract Drugs 0.000 claims 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 claims 1
- 229960004927 neomycin Drugs 0.000 claims 1
- 229930014626 natural product Natural products 0.000 abstract description 4
- 238000002845 discoloration Methods 0.000 abstract description 3
- 238000004332 deodorization Methods 0.000 abstract 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 22
- 239000000787 lecithin Substances 0.000 description 20
- 235000010445 lecithin Nutrition 0.000 description 20
- 229940067606 lecithin Drugs 0.000 description 20
- 239000003963 antioxidant agent Substances 0.000 description 18
- 235000006708 antioxidants Nutrition 0.000 description 18
- 230000000052 comparative effect Effects 0.000 description 16
- 239000004615 ingredient Substances 0.000 description 16
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 14
- 238000012360 testing method Methods 0.000 description 14
- 238000009472 formulation Methods 0.000 description 12
- 210000003491 skin Anatomy 0.000 description 12
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 11
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 11
- NSOXQYCFHDMMGV-UHFFFAOYSA-N Tetrakis(2-hydroxypropyl)ethylenediamine Chemical compound CC(O)CN(CC(C)O)CCN(CC(C)O)CC(C)O NSOXQYCFHDMMGV-UHFFFAOYSA-N 0.000 description 11
- 125000005250 alkyl acrylate group Chemical group 0.000 description 11
- 239000001768 carboxy methyl cellulose Substances 0.000 description 11
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 11
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 11
- 229920006037 cross link polymer Polymers 0.000 description 11
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 11
- 239000008213 purified water Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 9
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 8
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 8
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 8
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 8
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 8
- 235000005493 rutin Nutrition 0.000 description 8
- 229960004555 rutoside Drugs 0.000 description 8
- 231100000245 skin permeability Toxicity 0.000 description 8
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 7
- 239000012528 membrane Substances 0.000 description 7
- 210000004379 membrane Anatomy 0.000 description 7
- 150000003904 phospholipids Chemical class 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 229930007845 β-thujaplicin Natural products 0.000 description 7
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 5
- 206010040880 Skin irritation Diseases 0.000 description 5
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 5
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 230000000975 bioactive effect Effects 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 150000002978 peroxides Chemical class 0.000 description 5
- 231100000475 skin irritation Toxicity 0.000 description 5
- 230000036556 skin irritation Effects 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- DEGAKNSWVGKMLS-UHFFFAOYSA-N calcein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(O)=O)CC(O)=O)=C(O)C=C1OC1=C2C=C(CN(CC(O)=O)CC(=O)O)C(O)=C1 DEGAKNSWVGKMLS-UHFFFAOYSA-N 0.000 description 4
- 239000000306 component Substances 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 150000002515 isoflavone derivatives Chemical class 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 229960002378 oftasceine Drugs 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 210000002510 keratinocyte Anatomy 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 238000013112 stability test Methods 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- BOBLSBAZCVBABY-WPWUJOAOSA-N 1,6-diphenylhexatriene Chemical compound C=1C=CC=CC=1\C=C\C=C\C=C\C1=CC=CC=C1 BOBLSBAZCVBABY-WPWUJOAOSA-N 0.000 description 2
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 102000006992 Interferon-alpha Human genes 0.000 description 2
- 108010047761 Interferon-alpha Proteins 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 2
- 235000000072 L-ascorbyl-6-palmitate Nutrition 0.000 description 2
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 2
- HELHAJAZNSDZJO-OTWIGTIJSA-L disodium;(2s,3s)-2,3-dihydroxybutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](O)[C@H](O)C([O-])=O HELHAJAZNSDZJO-OTWIGTIJSA-L 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 125000005313 fatty acid group Chemical group 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 229940079322 interferon Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 238000003921 particle size analysis Methods 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 235000010352 sodium erythorbate Nutrition 0.000 description 2
- 239000004320 sodium erythorbate Substances 0.000 description 2
- 235000019983 sodium metaphosphate Nutrition 0.000 description 2
- 235000019830 sodium polyphosphate Nutrition 0.000 description 2
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 description 2
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- MLIKYFGFHUYZAL-UHFFFAOYSA-K trisodium;hydron;phosphonato phosphate Chemical compound [Na+].[Na+].[Na+].OP([O-])(=O)OP([O-])([O-])=O MLIKYFGFHUYZAL-UHFFFAOYSA-K 0.000 description 2
- 229960004799 tryptophan Drugs 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 244000308180 Brassica oleracea var. italica Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 241000167550 Centella Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 1
- 230000001064 anti-interferon Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229940044176 ceramide 3 Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 229940107161 cholesterol Drugs 0.000 description 1
- 239000008358 core component Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 238000002875 fluorescence polarization Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 235000006539 genistein Nutrition 0.000 description 1
- 229940045109 genistein Drugs 0.000 description 1
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 1
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000006303 immediate early viral mRNA transcription Effects 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000002356 laser light scattering Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- XKLJHFLUAHKGGU-UHFFFAOYSA-N nitrous amide Chemical compound ON=N XKLJHFLUAHKGGU-UHFFFAOYSA-N 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000003658 preventing hair loss Effects 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003700 vitamin C derivatives Chemical class 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
- B23D—PLANING; SLOTTING; SHEARING; BROACHING; SAWING; FILING; SCRAPING; LIKE OPERATIONS FOR WORKING METAL BY REMOVING MATERIAL, NOT OTHERWISE PROVIDED FOR
- B23D61/00—Tools for sawing machines or sawing devices; Clamping devices for these tools
- B23D61/02—Circular saw blades
- B23D61/04—Circular saw blades with inserted saw teeth, i.e. the teeth being individually inserted
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
- B23D—PLANING; SLOTTING; SHEARING; BROACHING; SAWING; FILING; SCRAPING; LIKE OPERATIONS FOR WORKING METAL BY REMOVING MATERIAL, NOT OTHERWISE PROVIDED FOR
- B23D61/00—Tools for sawing machines or sawing devices; Clamping devices for these tools
- B23D61/02—Circular saw blades
- B23D61/025—Details of saw blade body
Landscapes
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
Description
실시예 1 | 실시예 2 | 실시예 3 | 실시예4 | 실시예 5 | 실시예 6 | 실시예 7 | 실시예 8 | 실시예 9 | 비교예 1 | 비교예 2 | |
포화 레시틴 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
불포화 레시틴 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 |
세라마이드 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
올리아놀릭산 | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | - | - |
콜레스테롤 마카다미에이트 | 0.1 | 0.4 | 0.5 | 0.8 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | - | - |
복합 항산화제 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | - | - |
인터페론 | - | - | - | - | 0.001 | - | - | - | - | - | - |
로즈마리 추출물 | - | - | - | - | - | 0.5 | 1.0 | 2.5 | 5 | - | 1.0 |
감초 추출물 | - | - | - | - | - | 0.25 | 1.0 | 1.25 | 2.5 | - | 1.0 |
포도씨 추출물 | - | - | - | - | - | 0.25 | 1.0 | 1.25 | 2.5 | - | 1.0 |
아크릴레이트/ 알킬아크릴 레이트 크로스 폴리머 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
카르복시메틸 셀룰로오스 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
망고 버터 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 |
카보폴 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
테트라히드록시프로필 에틸렌디아민 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
부틸렌 글리콜 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 |
스테아릴 알코올 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 |
정제수 | To 100 |
비교예 3 | 실시예 10 | 실시예 11 | 실시예 12 | 실시예 13 | 실시예 14 | |
포화 레시틴 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
불포화 레시틴 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 |
세라마이드 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
올리아놀릭산 | - | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 |
콜레스테롤 마카다미에이트 | - | 0.1 | 0.4 | 0.5 | 0.8 | 0.4 |
복합 항산화제 | - | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 |
레티놀 | - | - | - | - | - | 0.01 |
아크릴레이트/알킬아크릴레이트 크로스 폴리머 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
카르복시메틸 셀룰로오스 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
테트라히드록시프로필 에틸렌디아민 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
부틸렌 글리콜 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 |
스테아릴 알코올 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 |
정제수 | To 100 |
리포좀 평균 크기(nm) | |
비교예 1 | 224±9 |
실시예 1 | 214±11 |
실시예 2 | 158±21 |
실시예 3 | 132±4 |
실시예 4 | 129±19 |
비교예 1 | 실시예 9 | 실시예 8 | 실시예 7 | 실시예 6 | 실시예 2 | |
1일 | 219±5 | 206±7 | 163±7 | 155±6 | 136±8 | 135±5 |
7일 | 226±8 | 221±5 | 169±4 | 160±9 | 140±5 | 133±7 |
14일 | 241±5 | 231±9 | 177±8 | 162±5 | 141±7 | 140±8 |
30일 | 320±9 | 258±5 | 192±4 | 171±6 | 148±9 | 151±6 |
60일 | 352±7 | 279±3 | 201±3 | 175±3 | 155±4 | 160±8 |
실시예2 | 실시예4 | 실시예6 | 실시예7 | 실시예8 | 실시예9 | 비교예1 | 비교예2 | |
과산화물가 (meq/kg) | 3.2 | 3.1 | 3.8 | 3.9 | 4.3 | 4.6 | 3.5 | 4.1 |
실시예2 | 실시예4 | 실시예6 | 실시예7 | 실시예8 | 실시예9 | 비교예1 | 비교예2 | |
0일 | 3.2 | 3.1 | 3.8 | 3.9 | 4.3 | 4.6 | 3.5 | 4.1 |
7일 | 3.3 | 3.1 | 3.9 | 3.9 | 4.4 | 4.7 | 5.6 | 8.9 |
14일 | 3.9 | 3.5 | 4.2 | 4.3 | 4.7 | 5.1 | 8.9 | 12.8 |
30일 | 4.1 | 4.0 | 4.7 | 4.9 | 5.3 | 5.8 | 11.2 | 19.7 |
60일 | 4.5 | 4.2 | 5.3 | 5.9 | 5.9 | 6.9 | 18.9 | 28.9 |
Strip No. | 비교예 1 | 실시예 1 | 실시예 2 | 실시예 3 | 실시예 4 |
1 | 26.1±3.9 | 25.4±4.5 | 23.4±5.5 | 20.9±1.9 | 21.2±6.1 |
2 | 17.3±2.5 | 16.9±2.2 | 18.6±6.3 | 15.9±2.6 | 10.9±1.1 |
3 | 13.6±3.7 | 9.3±2.0 | 11.7±5.5 | 8.7±2.1 | 6.6±3.7 |
4-6 | 4.3±2.2 | 2.9±1.7 | 1.9±2.1 | 5.5±3.2 | 2.9±2.2 |
7-9 | 2.5±1.5 | 4.1±0.9 | 1.6±1.1 | 3.5±0.9 | 3.3±1.8 |
10-12 | 3.0±2.1 | 2.2±3.1 | 2.3±1.5 | 2.2±3.1 | 1.5±1.9 |
13-15 | 3.6±1.0 | 2.7±1.3 | 2.9±1.8 | 2.9±0.7 | 2.8±2.8 |
합 계 | 70.4±6.7 | 63.5±10.2 | 62.4±4.8 | 59.6±7.8 | 49.2±5.1 |
비교예 1 | 실시예 2 | 실시예 6 | 실시예 7 | 실시예 8 | 실시예 9 | |
피부 자극도(%) | 0 | 0 | 0 | 0 | 0 | 0 |
성분명 | 함량(%) | 성분명 | 함량(%) |
레시틴 | 0.4 | Niacinamide | 0.50 |
수첨 레시틴 | 1.5 | 이소플라본 | 0.1 |
세라마이드 | 0.1 | Hinokitiol | 0.15 |
올리아놀릭산 | 0.1 | 카르복시메틸셀루로오스 | 0.2 |
콜레스테롤 마카다미에이트 | 0.4 | 망고버터 | 1.0 |
복합 항산화제 | 1.0 | 아크릴레이트/알킬 아크릴레이트 크로스 폴리머 | 0.3 |
Zinc PCA | 1.0 | 카보폴 | 0.3 |
Trehalose | 1.0 | 테트라히드록시프로필 에틸렌디아민 | 0.1 |
Centella asiatica | 0.3 | 부틸렌 글리콜 | 3.0 |
신이화 추출물 | 1.0 | 스테아릴 알코올 | 2.0 |
석류 추출물 | 1.0 | 정제수 | 적량 |
Rutin | 0.01 |
성분명 | 함량(%) | 성분명 | 함량(%) |
레시틴 | 0.4 | 알로에 추출물 | 1.0 |
수첨 레시틴 | 1.5 | 비타민 C | 0.01 |
세라마이드 | 0.1 | Hinokitiol | 0.15 |
올리아놀릭산 | 0.1 | 카르복시메틸셀루로오스 | 0.2 |
콜레스테롤 마카다미에이트 | 0.4 | 망고버터 | 1.0 |
복합 항산화제 | 1.0 | 아크릴레이트/알킬 아크릴레이트 크로스 폴리머 | 0.3 |
이소플라본 | 1.0 | 카보폴 | 0.3 |
Trehalose | 1.0 | 테트라히드록시프로필 에틸렌디아민 | 0.1 |
레즈베라트롤 | 1.0 | 부틸렌 글리콜 | 3.0 |
감초 추출물 | 1.0 | 스테아릴 알코올 | 2.0 |
아데노신 | 0.04 | Rutin | 0.01 |
콜라겐 | 0.1 | 정제수 | 적량 |
석류 추출물 | 1.0 |
성분명 | 함량(%) | 성분명 | 함량(%) |
레시틴 | 0.4 | Niacinamide | 0.50 |
수첨 레시틴 | 1.5 | Rutin | 0.01 |
세라마이드 | 0.1 | Hinokitiol | 0.15 |
올리아놀릭산 | 0.1 | 카르복시메틸셀루로오스 | 0.2 |
콜레스테롤 마카다미에이트 | 0.4 | 망고버터 | 1.0 |
복합 항산화제 | 1.0 | 아크릴레이트/알킬 아크릴레이트 크로스 폴리머 | 0.3 |
Urea | 2.0 | 카보폴 | 0.3 |
glycerine | 3.0 | 테트라히드록시프로필 에틸렌디아민 | 0.1 |
Centella asiatica | 0.3 | 부틸렌 글리콜 | 3.0 |
로즈마리 추출물 | 1.0 | 스테아릴 알코올 | 2.0 |
감초 추출물 | 1.0 | 정제수 | 적량 |
성분명 | 함량(%) | 성분명 | 함량(%) |
레시틴 | 0.4 | 글라브리딘 | 0.10 |
수첨 레시틴 | 1.5 | Rutin | 0.01 |
세라마이드 | 0.1 | Hinokitiol | 0.15 |
올리아놀릭산 | 0.1 | 카르복시메틸셀루로오스 | 0.2 |
콜레스테롤 마카다미에이트 | 0.4 | 망고버터 | 1.0 |
복합 항산화제 | 1.0 | 아크릴레이트/알킬 아크릴레이트 크로스 폴리머 | 0.3 |
알부틴 | 2.0 | 카보폴 | 0.3 |
Vitamin C palmitate | 2.0 | 테트라히드록시프로필 에틸렌디아민 | 0.1 |
감초 추출물 | 1.0 | 부틸렌 글리콜 | 3.0 |
레즈베라트롤 | 0.5 | 스테아릴 알코올 | 2.0 |
석류 추출물 | 1.0 | 정제수 | 적량 |
성분명 | 함량(%) | 성분명 | 함량(%) |
레시틴 | 0.4 | Glycerine | 1.0 |
수첨 레시틴 | 1.5 | Rutin | 0.01 |
세라마이드 | 0.1 | Hinokitiol | 0.15 |
올리아놀릭산 | 0.1 | 카르복시메틸셀루로오스 | 0.2 |
콜레스테롤 마카다미에이트 | 0.4 | 망고버터 | 1.0 |
복합 항산화제 | 1.0 | 아크릴레이트/알킬 아크릴레이트 크로스 폴리머 | 0.3 |
Urea | 1.0 | 카보폴 | 0.3 |
Trehalose | 1.0 | 테트라히드록시프로필 에틸렌디아민 | 0.1 |
Centella asiatica | 0.3 | 부틸렌 글리콜 | 3.0 |
신이화 추출물 | 0.5 | 스테아릴 알코올 | 2.0 |
미나리 추출물 | 0.5 | 정제수 | 적량 |
자몽 추출물 | 0.5 |
성분명 | 함량(%) | 성분명 | 함량(%) |
레시틴 | 0.2 | Genistein | 1.0 |
수첨 레시틴 | 0.75 | Rutin | 0.01 |
세라마이드 | 0.05 | Hinokitiol | 0.15 |
올리아놀릭산 | 0.1 | 카르복시메틸셀루로오스 | 0.05 |
콜레스테롤 마카다미에이트 | 0.4 | 망고버터 | 0.2 |
복합 항산화제 | 1.0 | 아크릴레이트/알킬 아크릴레이트 크로스 폴리머 | 0.3 |
Zinc PCA | 1.0 | 카보폴 | 0.01 |
Trehalose | 1.0 | 테트라히드록시프로필 에틸렌디아민 | 0.1 |
은행잎 추출물 | 0.5 | 부틸렌 글리콜 | 3.0 |
녹차 추출물 | 0.5 | 스테아릴 알코올 | 2.0 |
석류 추출물 | 0.5 | 정제수 | 적량 |
마늘 추출물 | 0.5 |
성분명 | 함량(%) | 성분명 | 함량(%) |
레시틴 | 0.4 | 감초 추출물 | 1.0 |
수첨 레시틴 | 1.5 | Rutin | 0.01 |
세라마이드 | 0.1 | Hinokitiol | 0.15 |
올리아놀릭산 | 0.1 | 카르복시메틸셀루로오스 | 0.2 |
콜레스테롤 마카다미에이트 | 0.4 | 망고버터 | 1.0 |
복합 항산화제 | 1.0 | 아크릴레이트/알킬 아크릴레이트 크로스 폴리머 | 0.3 |
로즈마리 추출물 | 1.0 | 카보폴 | 0.3 |
Trehalose | 1.0 | 테트라히드록시프로필에틸렌디아민 | 0.1 |
Centella asiatica | 0.3 | 부틸렌 글리콜 | 3.0 |
신이화 추출물 | 1.0 | 스테아릴 알코올 | 2.0 |
석류 추출물 | 1.0 | 정제수 | 적량 |
성분명 | 함량(%) | 성분명 | 함량(%) |
레시틴 | 0.4 | 이소플라본 | 1.0 |
수첨 레시틴 | 1.5 | Cimicifuga Racemosa root 추출물 | 0.5 |
세라마이드 | 0.1 | Angelica Polymorpha Sinensis root 추출물 | 0.1 |
올리아놀릭산 | 0.1 | 포도씨 추출물 | 0.1 |
콜레스테롤 마카다미에이트 | 0.4 | Camellia Oleifera Seed 추출물 | 0.1 |
복합 항산화제 | 1.0 | 아크릴레이트/알킬 아크릴레이트 크로스 폴리머 | 0.3 |
Kudze root 추출물 | 1.0 | 카보폴 | 0.3 |
Wild yam 추출물 | 1.0 | 테트라히드록시프로필 에틸렌디아민 | 0.1 |
Pueraria milifica | 1.0 | 부틸렌 글리콜 | 3.0 |
레즈베라트롤 | 1.0 | 망고버터 | 1.0 |
석류 추출물 | 1.0 | 카르복시메틸셀루로오스 | 0.2 |
Scutellaria Galericulata 추출물 | 0.5 | 부틸렌 글리콜 | 3.0 |
클로버 추출물 | 0.5 | Rutin | 0.01 |
브로콜리 추출물 | 0.5 | 스테아릴 알코올 | 2.0 |
콜라겐 | 0.5 | 정제수 | 적량 |
Claims (25)
- (a) 조성물 총 중량에 대해 0.2 내지 4.0 중량%의 디올레오일 포스파티딜콜린(DOPC), 디스테아로일 포스파티딜콜린(PSPC), 및 디팔미토일 포스파티딜콜린(DPPC)으로 구성되는 군으로부터 선택되는 포화 및 불포화 레시틴과,(b) 조성물 총 중량에 대해 0.2 내지 4.0 중량%의 세라마이드와,(c) 조성물 총 중량에 대해 0.1 내지 1.0 중량%의 올리아놀릭산, 올리아놀릭산 유도체 및 이성질체로 구성되는 군으로부터 선택되는 펜타싸이클릭 트리터핀산과,(d) 조성물 총 중량에 대해 0.1 내지 1.0 중량%의 콜레스테롤, 콜레스테릴 아세테이트, 콜레스테릴 이소스테아레이트, 및 콜레스테릴 마카다미에이트로 구성되는 군으로부터 선택되는 스테롤을 주성분으로 하는 나노리포좀 조성물.
- 삭제
- 삭제
- 삭제
- 제1항에 있어서, 불포화 레시틴과 포화 레시틴 및 세라마이드를 중량비로 0.4:1.5:0.1 의 비율로 함유함을 특징으로 하는 나노리포좀 조성물.
- 제1항에 있어서, 포화 및 불포화 레시틴의 혼합물을 조성물 총 중량을 기준으로 0.2 내지 6 중량% 함유함을 특징으로 하는 나노리포좀 조성물.
- 제1항에 있어서, 세라마이드를 조성물 총 중량을 기준으로 0.2 내지 3.0 중량% 함유함을 특징으로 하는 나노리포좀 조성물.
- 제1항에 있어서, 펜타싸이클릭 트리터핀산을 조성물 총 중량을 기준으로 0.2 내지 0.6 중량% 함유함을 특징으로 하는 나노리포좀 조성물.
- 제1항에 있어서, 스테롤을 조성물 총 중량을 기준으로 0.2 내지 0.6 중량% 함유함을 특징으로 하는 나노리포좀 조성물.
- 삭제
- 제1항에 있어서, 신이화 추출물, 석류 추출물, 히노키티올, 센텔라 아시아티카, Zinc PCA, 이소플라본 및 니아신아마이드로 구성되는 군으로부터 선택되는 하나 이상의 성분을 더 포함하는 나노리포좀 조성물.
- 삭제
- 제1항에 있어서, 알로에 추출물, 레즈베라트롤, 이소플라본, 감초 추출물, 석류 추출물, 아데노신, 콜라겐, 및 비타민 C로 구성되는 군으로부터 선택되는 하나 이상의 성분을 더 포함하는 나노리포좀 조성물.
- 삭제
- 제1항에 있어서, 니아신아마이드, 로즈마리 추출물, 감초 추출물, 및 센텔라 아시아티카로 구성되는 군으로부터 선택되는 하나 이상의 성분을 더 포함하는 나노리포좀 조성물.
- 삭제
- 제1항에 있어서, 알부틴, 비타민 C, 글라브리딘, 및 레즈베라트롤로 구성되는 군으로부터 선택되는 하나 이상의 성분을 더 포함하는 나노리포좀 조성물.
- 삭제
- 제1항에 있어서, 자몽 추출물, 신이화 추출물, 미나리 추출물, 및 센텔라 아시아티카로 구성되는 군으로부터 선택되는 하나 이상의 성분을 더 포함하는 나노리포좀 조성물.
- 삭제
- 제1항에 있어서, 은행잎 추출물, Zinc PCA, 녹차 추출물, 석류 추출물, 이소플라본, 및 마늘 추출물로 구성되는 군으로부터 선택되는 하나 이상의 성분을 더 포함하는 나노리포좀 조성물.
- 삭제
- 제1항에 있어서, 로즈마리 추출물, 신이화 추출물, 감초 추출물, 석류 추출물, 및 센텔라 아시아티카로 구성되는 군으로부터 선택되는 하나 이상의 성분을 더 포함하는 나노리포좀 조성물.
- 삭제
- 제1항에 있어서, Kudze root 추출물, 포도씨 추출물, 이소플라본, 클로버 추출물, Wild yam 추출물, Pueraria milifica, 레즈베라트롤, 석류 추출물, Scutellaria Galericulata 추출물, 브로콜리 추출물, cimicifuga Racemosa root 추출물, 콜라겐, Angelica Polymorpha Sinensis root 추출물, Camellia Oleifera Seed 추출물로 구성되는 군으로부터 선택되는 하나 이상의 성분을 더 포함하는 나노리포좀 조성물.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040016334A KR100603814B1 (ko) | 2004-03-11 | 2004-03-11 | 나노리포좀 조성물 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040016334A KR100603814B1 (ko) | 2004-03-11 | 2004-03-11 | 나노리포좀 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040027829A KR20040027829A (ko) | 2004-04-01 |
KR100603814B1 true KR100603814B1 (ko) | 2006-07-25 |
Family
ID=37330192
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020040016334A KR100603814B1 (ko) | 2004-03-11 | 2004-03-11 | 나노리포좀 조성물 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100603814B1 (ko) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100824958B1 (ko) * | 2006-12-05 | 2008-04-28 | 주식회사 피코스텍 | 한방 추출물과 나노 세라마이드를 함유하는 화장품 조성물 |
KR100834687B1 (ko) * | 2007-02-21 | 2008-06-02 | 주식회사 엘지생활건강 | 히노키티올 함유 지질 나노 입자 및 그의 제조방법 |
KR101594687B1 (ko) | 2014-08-28 | 2016-02-18 | (주)미애부생명과학 | 천연 리포좀 및 그 제조방법 |
KR20160062951A (ko) | 2014-11-26 | 2016-06-03 | (주)미애부생명과학 | 세라마이드를 포함하는 천연리포좀, 그 제조방법, 및 이를 포함하는 화장료 조성물 |
KR101779671B1 (ko) | 2015-11-11 | 2017-09-19 | (주)엠앤씨생명과학 | 사카로미세스속 효모 추출물을 포함하는 천연 리포좀, 그 제조방법 및 이를 포함하는 식품 또는 약학 조성물 |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006014035A1 (en) * | 2004-08-06 | 2006-02-09 | Biospectrum, Inc. | Multiple layered liposome and preparation method thereof |
KR100713555B1 (ko) | 2004-11-23 | 2007-05-04 | 주식회사 코리아나화장품 | 세라마이드를 포접하여 안정화시킨 나노리포좀을유효성분으로 함유하는 모발 보호용 조성물 |
KR100715311B1 (ko) * | 2005-08-24 | 2007-05-07 | 한국콜마 주식회사 | 경피흡수가 증진되고 우르솔산이 안정화된 주름개선 화장료및 그 제조방법 |
TWI373473B (en) * | 2005-09-02 | 2012-10-01 | Otsuka Pharma Co Ltd | Anticancer agent |
KR100705981B1 (ko) | 2005-10-12 | 2007-04-10 | 주식회사 리제론 | 인간 성장호르몬을 포함하는 탈모방지 또는 발모촉진용조성물 |
KR100737101B1 (ko) * | 2006-02-18 | 2007-07-06 | 김재용 | 피부노화억제에 효과적인 아데노신의 리포좀 기술을 이용한안정화 기술 및 이를 함유하는 화장료 조성물과 그의제조방법 |
KR100670440B1 (ko) * | 2006-02-22 | 2007-01-16 | 주식회사 하이넷포쉬에화장품 | 아데노신 및 유용성 감초 추출물의 리포좀 기술을 이용한안정화 기술 및 이를 함유하는 화장료 조성물과 그의제조방법 |
KR100747502B1 (ko) * | 2006-03-23 | 2007-08-08 | (주)더페이스샵코리아 | 피부 자극완화 복합체 및 이를 함유하는 화장료 조성물 |
KR100752990B1 (ko) * | 2006-08-02 | 2007-08-30 | 주식회사 대웅 | 나노리포좀 및 천연 추출물을 포함하는 피부 질환의 예방또는 치료용 조성물 |
KR100904370B1 (ko) * | 2007-10-15 | 2009-06-23 | 보령메디앙스 주식회사 | 나노리포좀을 함유하는 화장료 조성물 |
KR100954095B1 (ko) * | 2009-08-17 | 2010-04-23 | 심보미 | 체질에 따라 상이한 주름 예방 및 개선용 조성물 |
CN102793665A (zh) * | 2011-05-26 | 2012-11-28 | 河南羚锐制药股份有限公司北京药物研究院 | 一种原花青素柔性纳米脂质体及其制备方法 |
JP6026785B2 (ja) * | 2011-10-31 | 2016-11-16 | 富士フイルム株式会社 | 水性組成物 |
KR101582029B1 (ko) | 2014-04-08 | 2015-12-31 | 전라남도 | 갯벌 참굴 부상식 양성장치 |
US20220339136A1 (en) * | 2019-08-30 | 2022-10-27 | United States Government As Represented By The Department Of Veterans Affairs | Liposomal troponoid compound formulations |
KR102531980B1 (ko) * | 2022-08-18 | 2023-05-12 | 엘앤피코스메틱(주) | 병풀 추출물의 제조방법 및 이로부터 얻어진 병풀 추출물을 포함하는 화장료 조성물 |
-
2004
- 2004-03-11 KR KR1020040016334A patent/KR100603814B1/ko active IP Right Grant
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100824958B1 (ko) * | 2006-12-05 | 2008-04-28 | 주식회사 피코스텍 | 한방 추출물과 나노 세라마이드를 함유하는 화장품 조성물 |
KR100834687B1 (ko) * | 2007-02-21 | 2008-06-02 | 주식회사 엘지생활건강 | 히노키티올 함유 지질 나노 입자 및 그의 제조방법 |
KR101594687B1 (ko) | 2014-08-28 | 2016-02-18 | (주)미애부생명과학 | 천연 리포좀 및 그 제조방법 |
KR20160062951A (ko) | 2014-11-26 | 2016-06-03 | (주)미애부생명과학 | 세라마이드를 포함하는 천연리포좀, 그 제조방법, 및 이를 포함하는 화장료 조성물 |
KR101779671B1 (ko) | 2015-11-11 | 2017-09-19 | (주)엠앤씨생명과학 | 사카로미세스속 효모 추출물을 포함하는 천연 리포좀, 그 제조방법 및 이를 포함하는 식품 또는 약학 조성물 |
Also Published As
Publication number | Publication date |
---|---|
KR20040027829A (ko) | 2004-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100603814B1 (ko) | 나노리포좀 조성물 | |
US10709748B2 (en) | Encapsulated cannabinoid formulations for transdermal delivery | |
CN112891241B (zh) | 一种靶向线粒体皮肤抗衰纳米组合物及其制备方法和应用 | |
AU778261B2 (en) | Extracts of feverfew (tanacetum parthenium) against inflammatory disorders | |
US5614215A (en) | Cosmetic composition for the simultaneous treatment of the surface and deep layers of the skin, its use | |
EP1513492B1 (de) | Mikro-emulsionen mit binärer phasen- und wirkstoffdifferenzierbarkeit, deren herstellung und deren verwendung, insbesondere zur topischen sauerstoffversorgung | |
KR101199580B1 (ko) | 국소 투여용 나노에멀젼 | |
KR101355216B1 (ko) | 경피 흡수 촉진용 리포좀을 포함하는 조성물이 적용된 마스크 시트 | |
KR101821207B1 (ko) | 올레아놀릭산을 함유하는 화장료 조성물 | |
CA2534551C (en) | Cosmetic composition to assist transport of oxygen into the skin | |
US20140086977A1 (en) | Tight junctions modulators | |
EP1609461A1 (en) | Cosmetic compositions comprising a mixture of N-acyl-phosphatidylethanolamines and cosmetic treatments thereof. | |
US20110081387A1 (en) | Liposomes encapsulating an oxazolidin-2-one compound | |
KR101503301B1 (ko) | 레티닐팔미테이트 안정화 조성물 | |
KR102004147B1 (ko) | 리포좀화된 이데베논을 유효성분으로 포함하는 화장료 조성물 | |
RU2665946C2 (ru) | Композиция, содержащая луковый экстракт и липосомы | |
KR101072198B1 (ko) | 피부 미백용 화장료 조성물 | |
KR20190102753A (ko) | 피부흡수 촉진용 탄성 리포좀 조성물, 이를 포함하는 피부흡수 촉진용 탄성 리포좀 및 이의 제조방법 | |
DE10306724A1 (de) | Vesikuläre Verkapselung von Bendamustin | |
KR101512190B1 (ko) | 경피 전달용 아미덤 조성물 | |
KR101208120B1 (ko) | 비타민 복합체, 이를 제조하는 방법 및 이를 포함하는 화장료 조성물 | |
KR101607166B1 (ko) | 포스파티딜에탄올아민과 포스파티딜콜린을 포함한 리포좀을함유하는 피부 미백용 화장료 조성물 | |
KR100614816B1 (ko) | 안정한 나노 캡슐 조성물 및 그를 포함하는 화장료 | |
Blume | Flexible liposomes for topical applications in cosmetics | |
KR102575214B1 (ko) | 아줄렌 또는 그 유도체를 유효성분으로 함유하여 외부자극에 의한 피부 진정 효과가 우수하고, 민감성 피부 및 여드름성 피부에 적합하며, 피부 탄력 개선에 도움을 주는 탄성 리포좀 조성물 및 이를 포함하는 화장료 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
N231 | Notification of change of applicant | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130705 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140627 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20150619 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20170706 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20180807 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20190703 Year of fee payment: 14 |